Transaction #27500 · Form 4 · 0000905148-26-000036
Opus Genetics, Inc. · Stock award · Common Stock
Opus Genetics, Inc. · Transacted January 1, 2026 · Filed January 5, 2026
What does this filing report?
An SEC Form 4 filing for Opus Genetics, Inc. records a stock award involving Common Stock on January 1, 2026. The reported quantity was 31,188. The filing date is January 5, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Opus Genetics, Inc.
- Company CIK
- 0001228627
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 31,188
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 292,951
- Ownership description
- Not reported
- SEC acceptance time
- Jan 5, 2026, 4:23 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- MANUSO JAMES S J ↗
Director
CIK 0001236365
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The Reporting Person was granted shares of common stock in lieu of cash for board services for 2026. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock the day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $1.99 per share, the average of the high and low price of the common stock, the day prior to the grant date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.